• 1
    Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999; 27:14181427.
  • 2
    Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89:39193924.
  • 3
    Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337:373381.
  • 4
    Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339:15651577.
  • 5
    Lord BI, Woolford LB, Wood LM. Mobilization of early hematopoietic progenitor cells with BB-10010: A genetically engineered variant of human macrophage inflammatory protein-1 alpha. Blood 1995; 85:34123415.
  • 6
    Trentin JJ. Influence of hematopoietic organ stroma (hematopoietic inductive microenvironments) on stem cell differentiation. In: GordonA, ed. Regulation of Hematopoiesis. New York: Appleton-Century-Crafts,1970;Vol 1:161185.
  • 7
    Wolf NS. The haemopoietic microenvironment. Clin Haematol 1979; 8:469500.
  • 8
    Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 1996; 2:13291337.
  • 9
    Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845848.
  • 10
    Kollet O, Petit I, Kahn J et al. Human CD34(+)CXCR4(−) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 2002; 100:27782786.
  • 11
    Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276:7174.
  • 12
    Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143147.
  • 13
    Allen TD, Dexter TM. The essential cells of the hemopoietic microenvironment. Exp Hematol 1984; 12:517522.
  • 14
    Dexter TM, Allen TD, Lajtha LD. Conditions controlling the proliferation of hematopoietic stem cells in vivo. J Cell Physiol 1977; 91:335339.
  • 15
    Sutherland HJ, Lansdorp PM, Henkelman DH et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A 1990; 87:35843588.
  • 16
    Eaves CJ, Cashman JD, Kay RJ et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991; 78:110117.
  • 17
    Moore KA, Pytowski B, Witte L et al. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci U S A 1997; 94:40114016.
  • 18
    Karanu FN, Murdoch B, Miyabayashi T et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001; 97:19601967.
  • 19
    Noort WA, Kruisselbrink AB, in't Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/scid mice. Exp Hematol 2002; 30:870878.
  • 20
    Almeida-Porada G, Porada CD, Tran N et al. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in marrow at later time points after transplantation. Blood 2000; 95:36203627.
  • 21
    Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18:307336.
  • 22
    Koc ON, Lazarus HM. Mesenchymal stem cells: Heading into the clinic. Bone Marrow Transplant 2001; 27:244255.
  • 23
    Madhusudhan T, Majumdar SS, Mukhopadhyay A. Degeneration of stroma reduces retention of homed cells in bone marrow of lethally irradiated mice. Stem Cells Dev 2004; 13:173182.
  • 24
    Fouillard L, Bensidhoum M, Bories D et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003; 17:474476.
  • 25
    Koegler G, Sensken S, Airey JA et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200:123135.
  • 26
    Wang J-F, Wang L-J, Wu Y-F et al. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34+ hematopoietic stem cells and for chondrogenic differentiation. Haematologica 2004; 89:837844.
  • 27
    Kogler G, Radke TF, Lefort A et al. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 2005; 5:573583.
  • 28
    Ahmed F, Ings SJ, Pizzey AR et al. Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood 2004; 103:20792087.
  • 29
    Kahn J, Byk T, Jansson-Sjostrand L et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004; 103:29422949.
  • 30
    Mackin W, Gunter K, Kraus M. The frontier of cellular medicine: Expanding umbilical cord blood stem cells for clinical use. Cancer J 2001; 7(suppl 2):95105.
  • 31
    Glimm H, Tang P, Clark-Lewis I et al. Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice. Blood 2002; 99:34543457.
  • 32
    Li K, Chuen CK, Lee SM et al. Small peptide analog of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines, enhances their ex vivo expansion and engraftment into NOD/SCID mice. Stem Cells 2006; 24:5564.
  • 33
    Bensidhoum M, Chapel A, Francois S et al. Homing of in vitro expanded Stro-1- or Stro1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004; 103:33133319.
  • 34
    Kim DW, Chung YJ, Kim TG et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103:19411948.
  • 35
    Plett PA, Frankovitz SM, Wolber FM et al. Treatment of circulating CD34(+) cells with SDF-1 alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential. Exp Hematol 2002; 30:10611069.
  • 36
    Petit I, Goichberg P, Spiegel A et al. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest 2005; 115:168176.
  • 37
    Lu LL, Liu YJ, Yang SG et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006; 91:10171026.